Docket Room.
A 10521·NY·house

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state

In CommitteeFiled Mar 6, 2026
Sponsor: Andrew Hevesi (D)
Latest Action

PRINT NUMBER 10521A

Apr 7, 2026

Email me when A 10521 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track A 10521. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill expands the state’s newborn screening list to include CLN2, MPS IVA, MPS VI, MPS VII, and Fabry disease. It directs the health commissioner to make tests for these conditions available within twelve months of the law’s effective date. Early detection is intended to improve outcomes for affected infants and families.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about A 10521

3 free questions a day, no account

History

  1. PRINT NUMBER 10521A
  2. AMEND AND RECOMMIT TO HEALTH
  3. REFERRED TO HEALTH

Sponsors

  • Andrew Hevesi (D) · sponsor
  • Anna Kelles
  • Jo Anne Simon
  • MaryJane Shimsky
  • Nader Sayegh
  • Nily Rozic

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when A 10521 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track A 10521 free

Or ask your AI assistant about A 10521 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice